Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite

Abstract

Cytochrome P450 (P450) is a superfamily of enzymes which mediates metabolism of xenobiotics including drugs. Alprazolam, an anti-anxiety agent, is metabolized in rat and human liver by P4503A1 and P4503A4 respectively, to 4-hydroxy alprazolam (4-OHALP, pharmacologically less active) and α-hydroxy alprazolam (α-OHALP, pharmacologically more active). We examined P450 mediated metabolism of alprazolam by rat and human brain microsomes and observed that the relative amount of α-OHALP formed in brain was higher than liver. This biotransformation was mediated by a P450 isoform belonging to P4503A subfamily, which is constitutively expressed in neuronal cells in rat and human brain. The formation of larger amounts of α-OHALP in neurons points to local modulation of pharmacological activity in brain, at the site of action of the anti-anxiety drug. Since hydroxy metabolites of alprazolam are hydrophilic and not easily cleared through blood-CSF barrier, α-OHALP would potentially have a longer half-life in brain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14

Similar content being viewed by others

References

  1. de Montellano O . Cytochrome P-450: structure, mechanism and biochemistry Plenum Publishing: New York 1986

    Book  Google Scholar 

  2. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisin R et al . The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature DNA Cell Biol 1993 12: 1–12

    Article  CAS  Google Scholar 

  3. Guengerich FP, Liebler DC . Enzymatic activation of chemicals to toxic metabolites Crit Rev Toxicology 1985 14: 259–307

    Article  CAS  Google Scholar 

  4. Gonzalez FJ . Human cytochromes P450: problems and prospects Trends Pharmacol Sci 1992 13: 346–353

    Article  CAS  Google Scholar 

  5. Brosen K . Recent developments in hepatic drug oxidation: Implications for clinical pharmacokinetics Clin Pharmacokinet 1990 18: 220–239

    Article  CAS  Google Scholar 

  6. Guengerich FP . Characterization of human microsomal cytochrome P-450 enzyme Ann Rev in Pharmacology 1989 29: 241–2644

    Article  CAS  Google Scholar 

  7. Venkatakrishnan K, VonMoltke LL, Greenblatt DJ . Human drug metabolism and the cytochromes P450: application and relevance of in vitro models J Clin Pharmacol 2001 41: 1149–1179

    Article  CAS  Google Scholar 

  8. Gram TE, Okine LR, Gram RA . The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity Ann Rev Pharmacol Toxicol 1986 26: 259–291

    Article  CAS  Google Scholar 

  9. Boyd MR . Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation Crit Rev Toxicology 1980 7: 103–107

    Article  CAS  Google Scholar 

  10. Ravindranath V, Boyd MR . Xenobiotic metabolism in brain Drug Metabol Rev 1995 27: 419–448

    Article  CAS  Google Scholar 

  11. Michels R, Marzuk PM . Progress in Psychiatry (1) N Engl J Med 1993 329: 552–560

    Article  CAS  Google Scholar 

  12. Anandatheerthavarada HK, Shankar SK, Ravindranath V . Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms Brain Res 1990 536: 339–343

    Article  CAS  Google Scholar 

  13. Ravindranath V, Anandatheerthavarada HK, Shankar SK . Xenobiotic metabolism in human brain—presence of cytochrome P-450 and associated mono-oxygenases in human brain regions Brain Res 1989 496: 331–335

    Article  CAS  Google Scholar 

  14. Sethy VH, Harris DW . Determination of biological activity of alprazolam, triazolam and their metabolite J Pharm Pharmacol 1982 34: 115–116

    Article  CAS  Google Scholar 

  15. VonMoltke LL, Greenblatt DJ, Harmatz JS, Shader RI . Alprazolam metabolism in-vitro: studies of human, monkey, mouse and rat liver microsomes Pharmacology 1993 47: 268–276

    Article  CAS  Google Scholar 

  16. Fahey JM, Pritchard GA, Grassi JM, Pratt JS, Shader RI, Greenblatt DJ . In-situ hybridization histochemistry as a method to assess GABA-A receptor subunit mRNA expression following chronic alprazolam administration J Psychopharmac 1999 13: 211–218

    Article  CAS  Google Scholar 

  17. Chinta SJ, Pai HV, Upadhya SC, Boyd MR, Ravindranath V . Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain Mol Brain Res 2002 (In Press)

  18. Banks WR, Yamakita H, Digenis GA . Metabolism and distribution of 1-[14C] alprazolam in rats J Pharm Sci 1992 81: 797–801

    Article  CAS  Google Scholar 

  19. Upadhya SC, Chinta SJ, Pai HV, Boyd MR, Ravindranath V . Toxicological consequences of differential regulation of cytochrome P450 isoforms in rat brain regions by phenobarbital Arch of Biochem Biophys 2002 399: 56–65

    Article  CAS  Google Scholar 

  20. Glowinski J, Iversen LL . Regional studies of catecholamines in the rat brain. I. the disposition of [3H] norepinephrine, [3H] dopamine and [3H] DOPA in various regions of the brain J Neurochem 1966 13: 655–669

    Article  CAS  Google Scholar 

  21. Bradford MM . A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of dye binding Anal Biochem 1976 72: 248–254

    Article  CAS  Google Scholar 

  22. Laemmli UK, Favre M . Maturation of the head of bacteriophage T4, DNA packaging events J Mol Biol 1973 86: 574–599

    Google Scholar 

  23. Towbin M, Staehelin T, Gordon J . Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci 1979 76: 4350–4354

    Article  CAS  Google Scholar 

  24. Chomezynski P . A reagent for the single step simultaneous isolation of RNA, DNA and protein from cell and tissue samples Biotechniques 1993 15: 532–537

    Google Scholar 

  25. Kevil CG, Walsh L, Laroux S, Kalogeris T, Grisham MB, Alexander JS . An improved, rapid northern protocol Biochem Biophys Res Commun 1997 238: 277–279

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Dr SK Shankar, for providing the human brain tissue through Human Brain Tissue Repository for Neurobiological Studies, Department of Neuropathology, NIMHANS and Dr FP Guengerich for antiserum to P4503A4 and Dr NG Avadhani for providing the cDNA to CYP3A1. The technical assistance of Mr VK Prasanna is acknowledged. This research was supported by National Institutes of Health grant MH55494.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Ravindranath.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pai, H., Upadhya, S., Chinta, S. et al. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite. Pharmacogenomics J 2, 243–258 (2002). https://doi.org/10.1038/sj.tpj.6500115

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500115

Keywords

This article is cited by

Search

Quick links